Regeneron and Colorado Center for Personalized Medicine announce major new human genetics research collaboration

Regeneron and Colorado Center for Personalized Medicine announce major new human genetics research collaboration

AURORA -- New York-based Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and the Colorado Center for Personalized Medicine ( CCPM) at the University of Colorado Anschutz Medical Campus today... Read More

Tuesday May 12, 2020 Tags: Aurora, CCPM, Colorado Center for Personalized Medicine, Regeneron, Kathleen Barnes